Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Tax-Related Stock Disposal

Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported the disposal of shares to cover tax obligations related to vesting restricted stock.

Summary

• On March 23, 2024, Stephen P. Carey, the SVP & CFO of ANI Pharmaceuticals, disposed of 6,210 shares of common stock at a price of $69.58.
• This transaction was due to the withholding of shares for tax purposes related to the vesting of 13,618 shares of restricted stock.
• Following the transaction, Carey directly owns 171,502 shares of ANI Pharmaceuticals.
• The transaction was exempt under Rule 16(b)-3.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so it doesn't necessarily indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and future prospects.

Key Dates